Ola Ghatnekar

Estimating the value of novel interventions for Parkinson's disease: An early decision-making model with application to dopamine cell replacement. (2006)

Hjelmgren, Jonas, Ghatnekar, Ola, Reimer, Jan, Grabowski, Martin, Lindvall, Olle, Persson, Ulf, ...

Abstract is not available

Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries

Ola Ghatnekar, Ulf Persson, Michael Willis, Knut Odegaard

Objective: The primary objective of this study was to estimate the cost effectiveness of treating diabetic foot ulcers with becaplermin (Regranex(R)) plus good wound care (GWC) compared with GWC...